CLASSICAL HODGKIN LYMPHOMA
Clinical trials for CLASSICAL HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CLASSICAL HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for CLASSICAL HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with tough cancers: immunotherapy drug shows promise
Disease control Recruiting nowThis study tests pembrolizumab, an immunotherapy that helps the immune system fight cancer, in children aged 6 months to 18 years with advanced melanoma, solid tumors, or lymphomas that have spread, returned, or not responded to prior treatment. The goal is to see if the drug can…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 01, 2026 15:29 UTC
-
New hope for young hodgkin patients: drug combo may cut radiation need
Disease control Recruiting nowThis study tests a new treatment for children, teens, and young adults (ages 2 to 34) with newly diagnosed classical Hodgkin lymphoma. The drug brentuximab vedotin replaces two older drugs in a standard chemo regimen, aiming to shrink tumors faster and reduce the need for radiati…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE2, PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
Lifestyle makeover for lymphoma survivors: a new hope for better living
Symptom relief Recruiting nowThis study tests whether a personalized healthy lifestyle plan can improve quality of life for people who have survived lymphoma (Hodgkin or certain types of non-Hodgkin). About 552 survivors, aged 18-50 and in remission for 3-10 years, will be randomly assigned to receive the li…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: NA • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Symptom relief
Last updated Apr 29, 2026 15:02 UTC
-
Blood test may predict hodgkin relapse in kids
Knowledge-focused Recruiting nowThis study is looking at whether a blood test that detects tumor DNA (called ctDNA) can help predict if Hodgkin lymphoma will come back in children and young adults under 25. Researchers will follow 400 participants over time to see if ctDNA levels at diagnosis and during treatme…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:51 UTC